Luca Giliberto MD PhD
Neurodegenerative, Dementia & Geriatrics
Assistant Professor-Northwell Health Neurology and Feinstein Institute for Medical Research
Join to view full profile
611 Northern BlvdSte 150 North Shorelijcushing Neuroscience InstituteGreat Neck, NY 11021
Phone+1 516-325-7000
Fax+1 516-325-7001
Dr. Giliberto is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellResidency, Neurology, 2012 - 2015
Nassau University Medical CenterInternship, Internal Medicine, 2011 - 2012
University of Milan Faculty of MedicineClass of 1999
Certifications & Licensure
NY State Medical License 2014 - 2028
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016
Publications & Presentations
PubMed
- Heme Oxygenase-1 Contributes to Dampening Proinflammatory Activation in the Human Microglial Cell Line HMC3 and Controls the Transcription Factor IRF5.Anna Lisa Furfaro, Paola Mancini, Mario Passalacqua, Jasmin Ortolan, Caterina Ivaldo
Biomolecules. 2026-07-14 - Endogenous neuroprotection in vascular cognitive impairment and dementia.Chunyan Li, Willians Tambo, Keren Powell, Luca Giliberto, Daniel Sciubba
Ebiomedicine. 2026-07-01 - Blood-Based Biomarkers Predict Differential Longitudinal Decline in Alzheimer's Disease Psychosis: Evidence from Two Cohorts.Jesus J Gomar, Marc L Gordon, Erica Christen, Luca Giliberto, Linda Keehlisen
Medrxiv. 2026-06-22
Journal Articles
- Association Between Psychosis in Elderly Patients with Alzheimer Disease and Impaired Social CognitionJeremy Koppel, Luca Giliberto, JAMA
Press Mentions
FDA Approves Alzheimer’s Drug Shown to Moderately Slow Cognitive Decline in Early Stages of the DiseaseJanuary 6th, 2023- Daily Recap: Healthy Lifestyle May Stave off Dementia; Tentative Evidence on Marijuana for MigraineJune 24th, 2020
- Five Healthy Lifestyle Choices Tied to Dramatic Cut in Dementia RiskJune 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
